Literature DB >> 21623465

Improved diabetes control in the elderly delays global cognitive decline.

J A Luchsinger1, W Palmas, J A Teresi, S Silver, J Kong, J P Eimicke, R S Weinstock, S Shea.   

Abstract

OBJECTIVES: To examine whether improved diabetes control is related to better cognitive outcomes.
DESIGN: Randomized control trial.
SETTING: A randomized trial of telemedicine vs. usual care in elderly persons with type 2 diabetes. PARTICIPANTS: Participants were 2169 persons 55 years and older with type 2 diabetes from New York City and Upstate New York. INTERVENTION: The diabetes case management intervention was implemented by a diabetes nurse, via a telemedicine unit in the participant's home, and in coordination with the primary care physician. MEASUREMENTS: Hemoglobin A1c (HbA1c), systolic blood pressure (SBP), and low density lipoprotein cholesterol (LDL), were measured at a baseline visit and at up to 5 annual follow-up visits. Global cognition was measured at those visits with the Comprehensive Assessment and Referral Evaluation (CARE). RESULT: In mixed models the intervention was related to slower global cognitive decline in the intervention group (p = 0.01). Improvements in HbA1c (p = 0.03), but not SBP or LDL, mediated the effect of the intervention on cognitive decline.
CONCLUSION: Improved diabetes control in the elderly following existing guidelines through a telemedicine intervention was associated with less global cognitive decline. The main mediator of this effect seemed to be improvements in HbA1c.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623465      PMCID: PMC3328757          DOI: 10.1007/s12603-011-0057-x

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  44 in total

1.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

Review 2.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

3.  Multilevel mediation modeling in group-based intervention studies.

Authors:  J L Krull; D P MacKinnon
Journal:  Eval Rev       Date:  1999-08

4.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors.

Authors:  R L Sacco; E J Benjamin; J P Broderick; M Dyken; J D Easton; W M Feinberg; L B Goldstein; P B Gorelick; G Howard; S J Kittner; T A Manolio; J P Whisnant; P A Wolf
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

5.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

6.  Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

Authors:  Vicki Thallas-Bonke; Carsten Lindschau; Bishoy Rizkalla; Leon A Bach; Geoffrey Boner; Matthias Meier; Hermann Haller; Mark E Cooper; Josephine M Forbes
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

7.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

8.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

9.  A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study.

Authors:  Steven Shea; Ruth S Weinstock; Jeanne A Teresi; Walter Palmas; Justin Starren; James J Cimino; Albert M Lai; Lesley Field; Philip C Morin; Robin Goland; Roberto E Izquierdo; Susana Ebner; Stephanie Silver; Eva Petkova; Jian Kong; Joseph P Eimicke
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

10.  Relation of diabetes to mild cognitive impairment.

Authors:  José A Luchsinger; Christiane Reitz; Bindu Patel; Ming-Xin Tang; Jennifer J Manly; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04
View more
  33 in total

1.  Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Authors:  Katherine J Bangen; Jayandra J Himali; Alexa S Beiser; Daniel A Nation; David J Libon; Caroline S Fox; Sudha Seshadri; Philip A Wolf; Ann C McKee; Rhoda Au; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

2.  Frailty and cognition: linking two common syndromes in older persons.

Authors:  T K Malmstrom; J E Morley
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

Review 3.  Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

Authors:  Almudena Areosa Sastre; Robin Wm Vernooij; Magali González-Colaço Harmand; Gabriel Martínez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

4.  Dementia: type 2 diabetes has a slow and insidious effect on cognition.

Authors:  Hiroyuki Umegaki
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

5.  Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease.

Authors:  Elissa C McIntosh; Daniel A Nation
Journal:  Diabetes Care       Date:  2019-03-04       Impact factor: 19.112

Review 6.  The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.

Authors:  Michael L Alosco; John Gunstad
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

7.  Sleep Quality and Cognitive Function in Type 1 Diabetes: Findings From the Study of Longevity in Diabetes (SOLID).

Authors:  Paola Gilsanz; Mary E Lacy; Michal Schnaider Beeri; Andrew J Karter; Chloe W Eng; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Jan-Mar       Impact factor: 2.703

Review 8.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

9.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

10.  Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.

Authors:  Stefan Walter; Jessica R Marden; Laura D Kubzansky; Elizabeth R Mayeda; Paul K Crane; Shun-Chiao Chang; Marilyn Cornelis; David H Rehkopf; Shubhabrata Mukherjee; M Maria Glymour
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.